v158866
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2011 (NCT01634529)
Timeline
Indications
Studied for
Mechanism of action
- Anandamide amidohydrolaseINHIBITOR
FAAH inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- v158866
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01748695 | Phase 2 | Jun 1, 2013 | Harvard University, Vernalis |
| NCT01634529 | Phase 1 | Mar 1, 2011 | Hammersmith Medicines Research, Vernalis |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Vernalis | For profit | 2 | 1 | 2 | 2011 |
| Hammersmith Medicines Research | For profit | 1 | 0 | 1 | 2011 |
| Harvard University | Academic/Hospital | 1 | 1 | 1 | 2013 |
3 organizations
Page 1 / 1